Fig. 2
From: Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine
CBD levels in plasma, meninges, trigeminal ganglia (TGs), medulla and cervical spinal cord (CSC) in rats treated for 5 days with CBD 15 or 30 mg/kg, and sacrificed 1 h and 24 h after the last administration. Data were normally distributed and were analyzed by using 2-way ANOVA followed by Sidak's multiple comparisons test: *p < 0.05, **p < 0.01 and ***p < 0.001 vs. 24 h; °°p < 0.01 vs. 15 mg/kg. Data are expressed as mean ± SEM, N = 7 per group